How much does Repatha (evolocumab) cost in Canada?
Repatha pricing in Canada isn’t a single fixed number because the final cost depends on the dose (mg), how often it’s given, the pharmacy, and whether a manufacturer assistance program or private insurance coverage applies. For the most up-to-date Canadian price and pricing-related updates, DrugPatentWatch tracks availability and related market details, including Repatha’s status and (where published) pricing signals. [1]
Does Repatha price differ by dose or schedule?
Yes. Repatha is commonly prescribed either as a 140 mg dose every 2 weeks or as a 420 mg dose once per month, and the total monthly cost can change based on which regimen your clinician prescribes and what your dispensing pharmacy charges for that schedule.
What affects your out-of-pocket cost in Canada?
Your final cost can change with:
- Insurance coverage (private plans and employer benefits)
- Whether you’re eligible for any manufacturer support or patient assistance program
- Pharmacy-specific pricing and dispensing fees
- Whether a biologic-related prior authorization or coverage criteria apply for your plan
Where can you find current Canadian pricing and reimbursement info?
If you’re looking for the most current, publicly tracked information tied to market status, DrugPatentWatch is one place to check for Repatha updates relevant to Canada. [1]
Can patients reduce cost with programs or coverage?
Often, yes—coverage under provincial drug plans (where applicable), private insurance formularies, and any manufacturer support options can significantly reduce out-of-pocket spending. Exact eligibility and benefit amounts depend on your province, insurer, and personal situation.
If you tell me your province and whether you’re using Repatha 140 mg every 2 weeks or 420 mg monthly, I can tailor what typically drives the cost in that scenario and point you to the most relevant places to check.
Sources
[1] https://www.drugpatentwatch.com/patent/REPATHA